Steatohepatitis/Metabolic Liver Disease News

SAN DIEGO — A significant proportion of alcoholic hepatitis cases remain unrecognized and correlate with higher 30-day mortality, hospital length of stay and ICU admission, according to results presented at Digestive Disease Week 2022.

The FDA has granted fast track designation to Pfizer for ervogastat in combination with clesacostat for treatment of patients with nonalcoholic steatohepatitis with liver fibrosis, according to a company press release.

Lean patients with nonalcoholic fatty liver disease were at greater risk for cardiovascular and chronic kidney disease compared with overweight or obese patients, according to a researcher at the Digestive Disease Week 2022 media briefing.

Worse fatigue at baseline among patients with nonalcohol steatohepatitis-related advanced fibrosis and cirrhosis correlated with a higher risk adverse clinical events, according to published results.

A noninvasive scoring system using routine laboratory data may help primary care providers screen for fibrotic nonalcoholic steatohepatitis and dysmetabolism in high-risk patients, according to a published study.

The Mediterranean diet, which may help reverse the early stages of nonalcoholic fatty liver disease, requires patience, practice and the development of new life skills, according to one expert dietician.

Napping for more than 60 minutes during the day positively correlated with risk for nonalcoholic fatty liver disease in an occupational population in China, according to research published in BMC Gastroenterology.

BMI, serum transaminase, pre-albumin levels and disease duration may predict the development of nonalcoholic fatty liver disease in patients with Crohn’s disease, according to research published in BMC Gastroenterology.

Nonalcoholic fatty liver disease remains widely undiagnosed, yet early identification and treatment could mitigate long-term risk for CVD, according to a new American Heart Association scientific statement.

Alcohol-associated liver disease mortality rates increased each year from 2017 to 2020 and accelerated during the COVID-19 pandemic, according to data published in Clinical Gastroenterology and Hepatology.